Our Vision
To create Centers of Excellence for global pharmaceutical product development, dedicated to bringing treatments to the market that help patients with life altering disease lead better lives.
We focus on:
Early stage compounds (pre-IND or phase I) that are a strategic fit
Previously approved compounds where we can improve the profile or pursue additional indications
Dormant late stage compounds that will require a minimal amount of additional clinical work for approval
Our Mission
To develop high potential assets with the capacity to be first in class or best in class while providing cost effective, reimbursable, and highly competitive solutions for patients and healthcare providers
To become the global partner of choice for developing products that will target the unmet needs of specialists in areas such as gastroenterology, oncology, and endocrinology
To partner with a committed group of investors and equity partners with the goal of maximizing the return on investment for all parties
Our Mission
To develop high potential assets with the capacity to be first in class or best in class while providing cost effective, reimbursable, and highly competitive solutions for patients and healthcare providers
To become the global partner of choice for developing products that will target the unmet needs of specialists in areas such as gastroenterology, oncology, and endocrinology
To partner with a committed group of investors and equity partners with the goal of maximizing the return on investment for all parties
Our Business Model
Following identification and acquisition of an asset a new portfolio company is formed that holds the intellectual property and has its own unique set of investors. After completion of phase II, each portfolio company would consider the following options:
Continue as a private VC-backed company
Enter into a partnership or joint venture with another company to complete Phase III studies and product launch
Spin the company out as an IPO to complete phase III and commercialize product (potential for marketing partner also available)